TRACON Pharmaceuticals, Inc. (TCON)

TRACON Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2	115	623	956	2,099	142
Market Cap Growth	-97.81%	-81.62%	-34.78%	-54.47%	1378.20%	-58.17%
Enterprise Value	-6	107	616	933	2,072	131
PE Ratio	-	-31.94	-21.27	-33.27	-121.15	-6.27
PS Ratio	0.13	9.52	-	2762.42	-	-
PB Ratio	-11.16	-141.67	-87.18	81.59	83.72	52.63
P/FCF Ratio	0.26	31.18	-23.74	-42.26	-123.14	-6.00
P/OCF Ratio	0.26	31.18	-23.76	-42.35	-123.17	-6.00
EV/Sales Ratio	0.97	8.88	-	2696.86	-	-
EV/EBITDA Ratio	-2.28	-15.55	-22.08	-32.92	-127.63	-5.87
EV/EBIT Ratio	-2.27	-15.51	-22.02	-32.99	-127.74	-5.87
EV/FCF Ratio	1.92	29.11	-23.45	-41.25	-121.52	-5.54
Debt / Equity Ratio	0	-1.20	-1.51	0.22	0.18	1.98
Debt / EBITDA Ratio	-	-0.14	-0.35	-0.05	-0.28	-0.24
Debt / FCF Ratio	-	0.26	-0.37	-0.06	-0.27	-0.23
Quick Ratio	0.76	0.84	0.78	1.76	3.43	1.39
Current Ratio	0.80	0.89	0.81	1.82	3.50	1.46
Asset Turnover	1.05	1.19	0	0.01	0	0
Interest Coverage	-60.60	-0.94	-28.06	-89.14	-29.77	-57.76
Return on Equity (ROE)	-99.21%	443.51%	409.90%	-245.23%	-69.10%	-839.81%
Return on Assets (ROA)	18.69%	-35.51%	-150.56%	-108.17%	-46.28%	-125.04%
Return on Capital (ROIC)	693.02%	-4338.36%	-1050.23%	-216.31%	-54.81%	-277.28%
Earnings Yield	108.56%	-3.13%	-4.70%	-3.01%	-0.83%	-15.96%
FCF Yield	381.09%	3.21%	-4.21%	-2.37%	-0.81%	-16.65%
Buyback Yield / Dilution	89.92%	-56.53%	-21.25%	-92.03%	-196.09%	-12.61%
Total Shareholder Return	89.92%	-56.53%	-21.25%	-92.03%	-196.09%	-12.61%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.